NCT06819735 2026-03-10
DOMISOL
Domain Therapeutics SA
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT06349837 2025-12-17
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sichuan University
Phase 1 Recruiting
NCT07285395 2025-12-16
AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Recruiting
NCT05916248 2025-04-01
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT06408688 2024-12-27
ISCA-CHECK
University Hospital, Basel, Switzerland
Phase 4 Recruiting
NCT06702566 2024-11-25
The Effect of Serum Ferritin in irAE
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting